Does CENEGERMIN-BKBJ Cause Therapy non-responder? 20 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Therapy non-responder have been filed in association with CENEGERMIN-BKBJ. This represents 0.2% of all adverse event reports for CENEGERMIN-BKBJ.
20
Reports of Therapy non-responder with CENEGERMIN-BKBJ
0.2%
of all CENEGERMIN-BKBJ reports
0
Deaths
0
Hospitalizations
How Dangerous Is Therapy non-responder From CENEGERMIN-BKBJ?
Of the 20 reports.
Is Therapy non-responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CENEGERMIN-BKBJ. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does CENEGERMIN-BKBJ Cause?
Eye pain (5,847)
Eye irritation (1,871)
Product dose omission issue (1,335)
Ocular hyperaemia (1,226)
Photophobia (1,065)
Vision blurred (944)
Wrong technique in product usage process (899)
Eye swelling (847)
Ocular discomfort (797)
Lacrimation increased (737)
What Other Drugs Cause Therapy non-responder?
ETANERCEPT (3,472)
APREMILAST (3,360)
METHOTREXATE (2,965)
RITUXIMAB (2,731)
ADALIMUMAB (2,595)
PREDNISONE (2,563)
TREPROSTINIL (2,289)
INFLIXIMAB (2,122)
TOCILIZUMAB (1,775)
HYDROXYCHLOROQUINE (1,699)
Which CENEGERMIN-BKBJ Alternatives Have Lower Therapy non-responder Risk?
CENEGERMIN-BKBJ vs CENOBAMATE
CENEGERMIN-BKBJ vs CEPHALEXIN
CENEGERMIN-BKBJ vs CERITINIB
CENEGERMIN-BKBJ vs CERLIPONASE ALFA
CENEGERMIN-BKBJ vs CERTICAN